← FDA DRUG APPROVALS

FDA NDA · NDA009452

MULTIFUGE

Sponsor: BLULINE

APPLICATION
NDA009452
TYPE
NDA
ORIGINAL APPROVAL
1954-07-12
LATEST ACTION
1954-07-12
ROUTE
ORAL
DOSAGE FORM
SYRUP
MARKETING STATUS
Discontinued

Products

MULTIFUGEDiscontinued
PIPERAZINE CITRATE EQ 500MG BASE/5ML · SYRUP · ORAL

Approval history

1954-07-12Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →